Details

Details

Title A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

IRB NRG-GY004

CC 16-360

Hospital Fairview, Hillcrest, Main Campus

Phase Phase 3

Disease Fallopian Tube, Gynecologic, Ovarian, Peritoneal

Drug Cediranib, Olaparib

Description

Description

Trial Description Not Available
Inclusion Criteria

Inclusion Criteria

Inclusion Criteria Not Available
Exclusion Criteria

Exclusion Criteria

Exclusion Criteria Not Available